The research was conducted by the M.D. Anderson Cancer Center. Dr. Qing Yi, the lead investigator of the study, said they are not yet testing this vaccine in clinical trials. He did not indicate if or when clinical testing may begin.

In this article you did not mention the name of the laboratory or manufacturer that owns the rights to this vaccine and what, if any, plans there are for human clinical study.
The in vivo results in rodents certainly seem promising.